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Abstract
Attrition is a potential source of bias in cohort studies. Although attrition may be inevitable in cohort studies of older
people, there is little empirical evidence as to whether bias due to such attrition is also inevitable. Anonymised primary care
data, routinely collected in clinical practice and independent of any cohort research study, represents an ideal unselected
comparison dataset with which to compare primary care data from consenting responders to a cohort study. Our objective
was to use this method as a novel means to assess if (i) responders at follow-up stages in a cohort study remain
representative of responders at baseline and (ii) attrition biases estimates of longitudinal associations. We compared
primary care consultation morbidities and prescription prevalences among circa 32,000 patients aged 50+ who contribute
to an anonymised general practice database (Consultations in Primary Care Archive (CiPCA)) with those from patients aged
50+ in the North Staffordshire Osteoarthritis Project (NorStOP) cohort, United Kingdom (2002–2008; n = 16,159). 8,197 (51%)
persons responded to the NorStOP baseline survey and consented to medical record review. 5,121 and 3,311 responded at
3- and 6-year follow-ups. Differences in consulting prevalence of non-musculoskeletal morbidities between NorStOP
responders and CiPCA comparison population did not increase over the two follow-up points except for ischaemic heart
disease. Differences observed at baseline for osteoarthritis-related consultations were generally unchanged at the two
follow-ups (standardised prevalence ratios for osteoarthritis (1.09–1.13) and joint pain (1.12–1.23)). Age and gender adjusted
associations between baseline consultation for chronic morbidity and future new osteoarthritis and related consultations
were similar in CiPCA (adjusted Hazard Ratio: 1.40; 95% Confidence Interval: 1.34,1.47) and NorStOP 6-year responders (1.32;
1.15,1.51). There was little evidence that responders at follow-ups represented any further selection bias to that present at
baseline. Attrition in cohort studies of older people does not inevitably indicate bias.
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Introduction
Cohort studies of health investigate the link between factors
measured at baseline and subsequent events in the future. Selective
recruitment into a cohort study may result in a difference in
prevalence of baseline characteristics between the ‘selected’ cohort
and the wider population from which it was derived [1–5].
However, simulation studies suggest the validity of associations
between baseline exposures and future outcomes is relatively
unaffected by such baseline selectivity [6].
Of more potential importance is future loss or drop-out of
initially recruited cohort participants (attrition). Although such
attrition may be inevitable in cohort studies of older people as
health and social difficulties develop with age, there is little
empirical evidence as to whether bias due to such attrition is also
inevitable - specifically whether (i) responders at follow-up stages in
a cohort study remain representative of responders at baseline and
(ii) attrition biases estimates of longitudinal associations. If cohort
attrition results in data that is missing not at random (MNAR), i.e.
the probability of drop-out depends on the outcome of interest and
cannot be explained by the observed exposures, then simulation
studies indicate this may lead to biased estimates of longitudinal
associations [7,8]. Although complete follow-up of all baseline
participants with no attrition is the best protection against possible
bias, this is rarely achieved in practice.
Predictors of attrition in cohort studies have often been
investigated by comparing the baseline characteristics of those
who participate at follow-up with those who drop out [4,9–16].
Other methods have been used to estimate the impact of non-
response: some studies have assumed that later responders (e.g.
those who respond to the second or third mailings of a
questionnaire) are more like non-responders than those who
respond to the first mailing [17], whilst others have collected
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minimum data from those not responding to standard survey
reminders [18,19].
An alternative approach is to directly compare independent
data from cohort responders with a comparison population which
represents the underlying population from which the cohort was
drawn. Routinely collected sources of information on health, such
as medical records from primary care or national registers, have
been used as comparison populations to assess response bias in
cross-sectional studies [5,20–23] and initial selection into a birth
cohort study [3]. We report here a novel extension of this
methodology, involving routine primary care medical record data
from survey responders, which is distinct and separate from their
survey data, and an available comparison population, also with
routinely collected primary care data, from an anonymised general
population medical record dataset which was broader than but
included the full populations from which survey participants had
been drawn. The comparison is performed at baseline and at each
subsequent follow-up stage of the cohort study. In this way,
consultation and prescription patterns in cohort responders can be
compared with those in the underlying population as an estimate
of the presence and extent of attrition bias.
We selected an existing cohort study of older people to test this
method empirically. The hypotheses tested were that, if there is no
systematic selectivity with respect to health among responders to
follow-up in the cohort study, then consultation-recorded
morbidity in such responders, collected from routine clinical
practice and independently of the cohort research, will not differ
from routine consultation morbidity frequency in a larger but
comparable general population unselected by study participation,
and that associations between record-based baseline measures and
record-based outcomes in the two populations will be similar.
Methods
Ethics Statement
For the North Staffordshire Osteoarthritis Project (NorStOP),
ethical approval was obtained from the North Staffordshire
Research Ethics Committee UK and written consent for medical
records to be reviewed was given by NorStOP participants. For
the Consultations in Primary Care Archive (CiPCA) database,
ethical approval was given by the North Staffordshire Research
Ethics Committee, UK to download and store anonymised
medical record information for research use from participating
general practices. All general practices participating in CiPCA
inform their patient populations that their anonymised records will
be used in this way and all patients are offered the opportunity to
withdraw their records from inclusion in CiPCA.
The Comparison Population
CiPCA is a database of routinely collected and anonymized
primary care data from 13 general practices in North Stafford-
shire, United Kingdom (UK), for which there is established
published quality with respect to the completeness and consistency
of morbidity recording during all consultations from their
registered populations [24]. In the UK, about 98% of persons
are registered with a general practice [25] for all routine primary
care, and their age-sex registers are considered to be representative
of the general population [26].
Annual consultation figures for musculoskeletal conditions
drawn from the CiPCA database have been shown to be similar
to national databases [27]. Data from the 11 CiPCA practices
which contributed data continuously from 2001 to 2008 were
included in this study. These 11 practices include 5 practices which
Table 1. The three time periods and denominator populations for NorStOP and CiPCA, North Staffordshire, UK (2000–2008).
Period covered Denominator population n Agea mean (SD) Female %
Time period 1
NorStOP 2 years prior to
baseline survey
All baseline survey
responders consenting
to record review
8,197 66.2 (10.06) 53
Comparison (CiPCA) Calendar years
2001–2002
All patients registered
between 1/1/2001 and
31/12/2002 and aged
50 or over at
31/12/2002
32,647 65.6 (10.77) 54
Time period 2
NorStOP 2 years prior to
1st follow-up survey
All 1st follow-up
survey responders
consenting to record review
5,121 67.7 (9.13) 54
Comparison (CiPCA) Calendar years
2004–2005
All patients registered
between 1/1/2004 and
31/12/2005 and aged
53 or over at 31/12/2005
32,830 67.3 (10.02) 54
Time period 3
NorStOP 2 years prior to 2nd
follow-up survey
All 2nd follow-up
survey responders
consenting to record review
3,311 69.3 (8.33) 55
Comparison (CiPCA) Calendar years
2007–2008
All patients registered
between 1/1/2007 and
31/12/2008 and aged
56 or over at 31/12/2008
30,280 69.1 (9.30) 54
NorStOP =North Staffordshire Osteoarthritis Project; CiPCA =Consultations in Primary Care Archive; SD = Standard deviation.
aAt end of time period.
doi:10.1371/journal.pone.0083948.t001
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participated in NorStOP and which were used for the current
analysis.
The NorStOP Cohort
NorStOP is a prospective cohort study of joint pain and general
health in older adults [28]. As part of this cohort study in North
Staffordshire, during 2002 and 2003 all people (n=16,159) aged
50 years and over who were registered with five general practices
were sent a postal questionnaire which incorporated a range of
validated self-report measures regarding joint pain, general health,
disability, psychological status and socio-demographics [28]. The
questionnaire also asked for consent to view medical records.
Electronic consultation and prescribing records for participants
consenting to review of their medical records was linked to
questionnaire self-report data. In order to limit the possibility of
people with joint pain being more likely to take part in the study,
the questionnaire was entitled ‘‘Health Questionnaire’’ and the
covering letter stated ‘‘We are very interested in your reply even if
you have not had any pain or other symptoms in the recent past’’,
although some reference to the study topic was made: ‘‘Research-
ers…are trying to find out about joint pain and other symptoms
experienced by people…’’. A 3-year follow-up questionnaire was
sent in 2005/2006 to those who responded to the baseline survey
and were still alive and registered with the practices. A 6-year
follow-up questionnaire was sent in 2008/2009. Details of
response within the NorStOP cohort at each time point have
been published previously [29–33].
The Analysis Design
The objective of the current analysis was to compare
consultation morbidity and prescription prevalence obtained
anonymously from the routine health care records of the CiPCA
comparison population, with the consultation morbidity and
prescription prevalence obtained from the routine health care
records of NorStOP responders at baseline, at three years and at
six years who had consented to use of their medical records. The
time periods for each comparison were determined by the timing
of the NorStOP surveys: i) the two years prior to the baseline
survey; ii) the two years prior to the 3-year follow-up survey; and
iii) the two years prior to the 6-year follow-up survey.
Consultations for nine specific morbidities were identified for
each time period based on recorded Read codes (see Appendix
S1). Read codes are a system of morbidity recording commonly
used in UK primary care [34]. Around 95% of consultations with
a general practitioner in CiPCA practices are Read coded.
Consultations for osteoarthritis (OA) and joint pain were included
as this was the main focus of the NorStOP study. Five other
chronic problems (ischaemic heart disease, diabetes, chronic
obstructive pulmonary disease (COPD), asthma and depression)
were included to give an indication of the general health of the
participants in NorStOP compared with the CiPCA comparison
population. Two acute conditions (otitis media and upper
respiratory tract infection (URTI)) were included as markers of
general consultation propensity and frequency.
Prescriptions for pain medication were also identified from
medical records in each time period. A hierarchical classification
of analgesia developed previously [35,36] was used and prescrip-
tions identified for any pain medication, basic analgesia (e.g.
paracetamol, topical non-steroidal anti-inflammatory drugs
(NSAIDs)), weak or moderate strength analgesia (e.g. coproxamol,
codeine less than 30 mg), strong or very strong analgesia (e.g.
codeine 30 mg, morphine) and oral NSAIDs.
For analysis of the comparison population, only patients
registered at the practices in CiPCA at both the start and end of
that period were included in the analysis. For the first time period
(the two years prior to the date of the baseline NorStOP survey),
the comparison population in CiPCA consisted of all fully
registered patients who were aged 50 years and over at the end
of the period. For the second (the two years prior to the 3-year
follow-up NorStOP survey) and third (the two years prior to the 6-
year follow-up NorStOP survey) time periods, the comparison
population were all registered patients aged 53 and over, and aged
56 and over, respectively.
For analysis of the NorStOP responders, analysis of medical
records for the first time period was performed on all responders at
baseline who consented to record review. For the second period,
the analysis was undertaken on the subgroup who also responded
at three years. For the third period, analysis was further restricted
to those who also responded at six years (Table 1).
Data Availability
The Research Institute for Primary Care & Health Sciences has
established data sharing arrangements to support joint publica-
tions and other research collaborations. Applications for access to
anonymised data from our research databases are reviewed by the
Institute’s Data Custodian and Academic Proposals Committee
and a decision regarding access to the data is made subject to the
National Research Ethics Service Research Ethics Committee’s
ethical approval first provided for the study and to new analysis
Figure 1. Flow diagram of responders to the North Stafford-
shire Osteoarthritis Project, United Kingdom (2002–2008).
aUnadjusted percentage responding before removing those who had
moved or died.
doi:10.1371/journal.pone.0083948.g001
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being proposed. Further information on our data sharing
procedures can be found on the Institute’s website (http://www.
keele.ac.uk/pchs/publications/datasharingresources/) or by
emailing the Institute’s data manager (primarycare.datasharing@
keele.ac.uk).
Statistical Analysis
For each time period, the two-year consultation prevalence for
both the NorStOP responders and CiPCA comparison population
was defined as the number of people with a record of consulting
primary care at least once for a morbidity during the relevant two
year time period, and is reported per 1,000 persons. 95%
confidence intervals (95% CI) were calculated for the consultation
prevalences within the NorStOP responder population assuming a
Poisson distribution. If the 95% CI included the prevalence for the
equivalent time period in the CiPCA comparison population, then
this suggested the estimates were similar.
NorStOP responders at each time period were then compared
again to the equivalent CiPCA comparison population with
respect to consultation prevalence using age and gender
standardised prevalence ratios (SPR), the CiPCA comparison
population being the standard. A standardised prevalence ratio is
the ratio of the prevalences of consultation for a particular
morbidity in each of the two populations, standardised for age and
gender using indirect standardisation. This analysis was repeated
for prescription prevalence based on the number of people
prescribed each type of pain medication during a time period,
again reported per 1,000 persons.
Finally, to assess whether there was any bias in longitudinal
associations identified in NorStOP responders compared to the
CiPCA comparison population, the association of chronic
morbidity at baseline with a future new record of a consultation
for OA or joint pain during the 6-year follow-up was assessed in
NorStOP 6-year responders. Chronic morbidity was defined as a
consultation for ischaemic heart disease, diabetes, COPD, asthma
or depression in the two years prior to baseline survey. Analysis
was restricted to those without a consultation for OA or joint pain
in the two years prior to the baseline survey. Time from baseline to
a new diagnosis of OA or joint pain was identified in the medical
records and the association of baseline morbidity with a future
diagnosis of OA or joint pain evaluated using Cox proportional
hazards regression, adjusted for age and gender. The proportion-
ality assumption was assessed graphically and using Schoenfeld
residuals [37], and deemed reasonable for this data. The analysis
was then repeated with OA as the sole outcome in those without a
record of OA prior to the baseline survey, with further adjustment
for a record of joint pain consultation in the two years prior to the
baseline survey. These analyses were then also performed in the
CiPCA comparison population in those registered for all of 2001
and 2002 (defined for this analysis as the ‘‘prior to baseline’’
period) with follow-up from 2003–2008. Patients in CiPCA were
censored at the point of death or leaving the practices.
Analysis was performed using Stata 12.1 for Windows.
Table 2. Two year consultation and prescription prevalence per 1,000 persons at each survey point in CiPCA comparison
population and NorStOP responders.
Baselinea 3 yearsb 6 yearsc
Comparison
population
NorStOP
responders
Comparison
population
NorStOP
responders
Comparison
population
NorStOP
responders
Prevalence
Prevalence
(95% CI) Prevalence
Prevalence
(95% CI) Prevalence
Prevalence
(95% CI)
Consultation prevalence
Osteoarthritis 80 93 (86, 100) 77 88 (80, 97) 79 88 (78, 98)
Joint pain 195 220 (210, 231) 206 254 (241, 268) 214 255 (238, 273)
Ischaemic heart disease 84 91 (84, 98) 101 123 (114, 133) 99 127 (115, 140)
Diabetes 63 65 (60, 71) 85 97 (89, 106) 108 111 (100, 123)
COPD 51 57 (52, 62) 49 60 (53, 67) 56 65 (57, 75)
Asthma 50 55 (50, 60) 60 69 (62, 77) 62 70 (61, 79)
Depression 67 51 (47, 57) 58 51 (45, 57) 50 53 (45, 61)
Otitis media 19 21 (18, 25) 15 20 (16, 24) 14 14 (10, 19)
URTI 89 84 (78, 91) 83 94 (85, 102) 88 92 (82, 103)
Prescription prevalence
Any pain medication 521 563 (547, 580) 502 568 (547, 589) 504 545 (521, 571)
Basic analgesia 266 256 (245, 267) 269 265 (251, 279) 297 289 (271, 308)
Weak/moderate analgesia 287 316 (304, 329) 264 313 (298, 329) 253 274 (257, 293)
Strong/very strong analgesia 105 136 (128, 144) 131 159 (148, 170) 168 190 (176, 206)
NSAIDs 207 236 (226, 247) 200 236 (223, 249) 149 185 (171, 200)
NorStOP =North Staffordshire Osteoarthritis Project; CiPCA =Consultations in Primary Care Archive; COPD=Chronic obstructive pulmonary disease; URTI =Upper
respiratory tract infection; NSAID =Non-steroidal anti-inflammatory drug; CI = Confidence interval.
aConsultation and prescriptions for the 2 years prior to baseline survey for NorStOP baseline responders; for CiPCA comparison population time period 2001–2002.
bConsultation and prescriptions for the 2 years before 3-year follow-up survey for NorStOP 3-year responders; for CiPCA comparison population time period 2004–2005.
cConsultation and prescriptions for the 2 years before 6-year follow-up survey for NorStOP 6-year responders; for CiPCA comparison population time period 2007–2008.
doi:10.1371/journal.pone.0083948.t002
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Results
Figure 1 shows the responders at each stage of the NorStOP
study. 11,209 responded at baseline. 8,197 of these consented to
review of their medical records and form the NorStOP cohort for
comparison in this analysis (i.e. 50.7% of the original target survey
population). Compared to those who responded but did not
consent to record review, consenters were slightly younger (mean
66.2 years vs. 67.4), had a lower proportion who were female (53%
vs. 62%) and reported more joint pain (79% vs. 70%). 5,121
(62.5%) of the 8,197 responded at three years. Of the three year
responders, 3,311 (65%) responded again at six years. Those who
consented to record review constituted 91% of all responders at
three years and 92% of responders at six years.
The CiPCA comparison population numbered 32,647 for the
first time period, 32,830 for the second time period, and 30,280 for
the third time period. Mean age and gender distribution were
similar between the comparison population and the NorStOP
responders for each time period (Table 1).
Compared with the CiPCA comparison population, NorStOP
responders had similar or slightly higher levels of consultation in
each time period for diabetes, COPD, asthma, otitis media and
URTI with no change in the differences with the comparison
population over the two follow-up points (Tables 2 and 3). The
comparison population had a slightly higher depression consulta-
tion prevalence in the first time period than the NorStOP
population. Ischaemic heart disease consultation prevalence was
higher in the NorStOP responders than the CiPCA comparison
population at 3-year and 6-year follow-ups (SPRs 1.18–1.25).
The two year consultation prevalence of OA was 13% higher
for the NorStOP responders than the CiPCA comparison
population at baseline, and this difference remained at both
follow-up points (SPRs 1.09–1.13 over the three time periods;
Table 3). There was a similar pattern, although with a slightly
larger difference between NorStOP and the CiPCA comparison
population, for joint pain consultation (SPRs 1.12–1.23).
There were consistently slightly higher two year prescription
prevalences of any pain medication (SPRs 1.07–1.12) and weak/
moderate analgesia (SPRS 1.07–1.17) in NorStOP responders
compared with the CiPCA comparison population. NSAID
prescription prevalence was 13% higher for NorStOP responders
at baseline, increasing to 25% at 6 years but strong analgesia
prescription prevalence fell from 29% higher in NorStOP
responders at baseline to 12% higher at 6 years (Table 3). Basic
analgesics were prescribed to a similar proportion of NorStOP
Table 3. Age and gender standardised prevalence ratios
(95% CI) comparing NorStOP responders at each survey point
to CiPCA comparison population.
Baselinea 3 yearsb 6 yearsc
Consultation
Osteoarthritis 1.13 (1.05, 1.22) 1.12 (1.02, 1.23) 1.09 (0.97, 1.22)
Joint pain 1.12 (1.07, 1.18) 1.23 (1.16, 1.30) 1.18 (1.10, 1.27)
Ischaemic heart
disease
1.03 (0.96, 1.10) 1.18 (1.09, 1.28) 1.25 (1.13, 1.37)
Diabetes 1.00 (0.91, 1.08) 1.10 (1.01, 1.20) 1.01 (0.91, 1.11)
COPD 1.07 (0.97, 1.17) 1.17 (1.04, 1.31) 1.13 (0.98, 1.29)
Asthma 1.10 (1.00, 1.20) 1.15 (1.03, 1.27) 1.10 (0.96, 1.25)
Depression 0.78 (0.71, 0.86) 0.90 (0.79, 1.02) 1.07 (0.91, 1.23)
Otitis media 1.17 (1.00, 1.35) 1.27 (1.04, 1.55) 0.96 (0.70, 1.28)
URTI 0.95 (0.88, 1.02) 1.12 (1.02, 1.23) 1.03 (0.91, 1.15)
Prescription
Any pain medication 1.07 (1.04, 1.10) 1.12 (1.08, 1.16) 1.08 (1.03, 1.13)
Basic analgesia 0.94 (0.90, 0.98) 0.97 (0.92, 1.02) 0.96 (0.90, 1.03)
Weak/moderate
analgesia
1.08 (1.04, 1.12) 1.17 (1.11, 1.22) 1.07 (1.00, 1.14)
Strong/very strong
analgesia
1.29 (1.21, 1.36) 1.21 (1.13, 1.29) 1.12 (1.04, 1.21)
NSAIDs 1.13 (1.08, 1.18) 1.18 (1.11, 1.25) 1.25 (1.15, 1.35)
NorStOP =North Staffordshire Osteoarthritis Project; CiPCA =Consultations in
Primary Care Archive; COPD=Chronic obstructive pulmonary disease;
URTI =Upper respiratory tract infection; NSAID =Non-steroidal anti-
inflammatory drug; CI = Confidence interval.
For age and gender standardised prevalence ratios, the comparison population
(CiPCA) = 1.00.
aConsultation and prescriptions for the 2 years prior to baseline survey.
bConsultation and prescriptions for the 2 years before 3-year follow-up survey.
cConsultation and prescriptions for the 2 years before 6-year follow-up survey.
doi:10.1371/journal.pone.0083948.t003
Table 4. Association of chronic morbidities with new record during follow-up of osteoarthritis, and osteoarthritis or joint pain, in
NorStOP and CiPCA.
Osteoarthritis Osteoarthritis or joint pain
CiPCA comparison
population
NorStOP 6-year
responders
CiPCA comparison
population
NorStOP 6-year
responders
Baseline population 32647 3311 32647 3311
No prior record of outcomea 30034 3033 24678 2413
Record of outcome during follow-up n (%) 3429 (11) 448 (15) 9358 (38) 1151 (48)
Unadjusted HR (95% CI) 1.38 (1.28, 1.48) 1.32 (1.07, 1.62) 1.41 (1.35, 1.47) 1.32 (1.15, 1.51)
Adjusted HRb (95% CI) 1.32 (1.23, 1.42) 1.30 (1.06, 1.60) 1.40 (1.34, 1.47) 1.32 (1.15, 1.51)
Adjusted HRc (95% CI) 1.25 (1.16, 1.34) 1.23 (1.00, 1.52) – –
NorStOP =North Staffordshire Osteoarthritis Project; CiPCA =Consultations in Primary Care Archive; COPD= chronic obstructive pulmonary disease; HR =Hazard ratio;
CI = Confidence interval.
Chronic morbidity defined as consultation for ischaemic heart disease, diabetes, COPD, asthma or depression prior to baseline.
aNo record of i) osteoarthritis and ii) osteoarthritis or joint pain in 2001 or 2002 (comparison) or in the 2 years prior to baseline survey (NorStOP).
bAdjusted for age and gender.
cAdjusted for age, gender and record of joint pain in 2001 or 2002 (comparison) or in the 2 years prior to baseline survey (NorStOP).
doi:10.1371/journal.pone.0083948.t004
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responders and patients in the comparison population (SPRs 0.94–
0.97) (Table 3).
The age and gender adjusted risk of future new consultation of
OA or joint pain in those with baseline chronic morbidity was
similar in the CiPCA comparison population (adjusted HR 1.40;
95% CI 1.34, 1.47) and the NorStOP 6-year responders (1.32;
1.15, 1.51; Table 4). This was also true when outcome was
restricted to new diagnosis of OA (comparison adjusted HR 1.25;
95% CI 1.16, 1.34; 6-year responders 1.23; 1.00, 1.52).
Discussion
This study provides evidence that directly comparing consulta-
tion data from cohort responders with that from an available
comparison population is a useful method for empirically
investigating attrition during follow-up in a cohort study of older
people. Our analysis of an existing cohort study shows that
attrition did not result in any substantial selection bias at follow-up
with respect to routinely recorded morbidities over a six year
period. We did, however, find evidence of initial baseline
selectivity at cohort recruitment among responders to the baseline
survey - baseline participants had consulted more frequently about
the topic of the study (OA and joint pain), and had received more
and stronger analgesia prescriptions than the comparison popu-
lation. However, there was little evidence that the cohort
responders at follow-up represented any further selectivity with
respect to the general population as a whole as represented by the
CiPCA comparison population, despite one-third attrition at each
stage of the NorStOP cohort follow-up. Furthermore, most other
morbidities showed little difference in baseline consultation
prevalence between NorStOP cohort responders and the CiPCA
comparison population, nor did follow-up cohort responders-to-
comparison population morbidity ratios alter in a consistent
pattern, apart from the particular example of ischaemic heart
disease which became relatively more frequent in the NorStOP
population than the comparison population at 6-year follow-up.
The latter is the one example in our data where initial selectivity
into the cohort (i.e. a higher proportion of people at baseline with
OA) may have resulted in additional selectivity at follow-up – a
recent prospective study also found an increased risk of ischaemic
heart disease among individuals with OA [38]. Finally, analysis of
an hypothesised association between baseline chronic morbidities
and future outcome (OA or joint pain) was no different in the
cohort responders and the comparison population, showing that
attrition did not result in biased estimates of the longitudinal
associations between the morbidities included and the study
outcome.
One explanation for initial selectivity into the cohort was the
baseline questionnaire documentation which, although focused on
general health, contained cues sufficient to encourage patients
‘‘with an interest’’ in joint pain to participate. Previous studies
have found that survey responders with the topic under
investigation are more likely to consent to medical record access
[39–41] or to consult [17]; however, there is also evidence that
survey participants do not change their consulting behaviour after
completing a health-related questionnaire [42]. By contrast, the
evidence for differences in health between participants and non-
participants in cohort studies of older adults shows that non-
participation at follow-up is more likely in those reporting poorer
health [4,9,12] and cognitive impairment [4,10,11,43], which
provides one explanation of the finding that baseline participants
had been less likely to consult about depression. However there is
no complete consensus on this issue [11,44,45].
The consequence of baseline selectivity means that absolute
percentages of people with joint pain and OA and taking analgesia
derived from the baseline survey may overestimate rates in the
general population. However, this does not affect the main
questions we were concerned with in the current analysis: the
subsequent impact of attrition during follow-up on the internal
validity of longitudinal analysis of the cohort. As long as there is
variation in the predictor variable of interest at baseline and
sufficient persons are either exposed or not exposed to it to make
the outcome of a cohort study viable and powerful enough to
detect differences if they exist, then the actual representativeness of
the baseline recruited sample of a putative population for a cohort
study may not inevitably influence the associations derived from
analysis between baseline and subsequent follow-up stages.
Our study has several strengths. Firstly, the existing cohort was
a large general population survey of older people with a high
response to the questionnaire at each stage. Secondly, although we
have previously reported the levels of attrition at each stage of the
NorStOP cohort [29–33], our novel method of empirically
examining the impact of attrition on the selectivity of the
followed-up population and on estimates of longitudinal associa-
tions now provides evidence that the application of a ‘‘follow-up
rate criterion’’ applied to cohort studies may be unreasonable.
Thirdly, the quality of CiPCA data is high due to the cycle of
training, assessment and feedback undertaken [24] and prevalence
of musculoskeletal conditions is comparable to that of larger
national general practice databases [27].
A limitation of this study is that we report only on the results of
applying our method within one existing cohort. Therefore the
absence of major attrition bias found in this study may not be
generalisable to other cohort studies with, for example, younger
participants, or other morbidities. However, routinely collected
primary care data of high quality from the wider general
population in countries such as the UK is becoming increasingly
available to researchers [46,47]. Hence, there is the opportunity
both to repeat our empirical investigation in other settings and for
this method to be used more widely to assess selectivity and bias in
cohort studies where consent for linkage to medical records has
been obtained and comparison population health care data is
available. One practical conclusion from our study is that routinely
collected health care data provide one independent source of
validation of follow-up in cohort studies and trials. Although such
data has not often been available linked to cohort studies in the
past, the increasing harnessing and linkage of large health care
datasets for epidemiological purposes, for example in cardiovas-
cular disease [48], offer the potential for this to become a more
widely available component of cohort study design and validation
in the future.
A further limitation is that our analysis is based on cohort
responders consenting to medical record review, who were
different on some baseline factors such as age and self-reported
joint pain to those who responded but did not consent. However,
as over 90% of all responders at the two follow-up points
consented to record review, they can be considered to fairly reflect
the responding population as a whole. In particular, as we have
shown before, the possible loss to follow-up from refusal to consent
to use of medical records (as distinct from providing replies to
questionnaires) does not seem to introduce bias into longitudinal
samples [41].
In conclusion, this study provides evidence for a useful method
for investigating bias due to attrition in a cohort study of older
people and for its potential application to assess selectivity and bias
in other cohort studies where consent for linkage to medical
records has been obtained and comparison population data is
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available. Our particular results also contribute empirical evidence
that, although the occurrence of attrition in a cohort study should
always be investigated as recommended by guidelines such as
STROBE (strengthening the reporting of observational studies in
epidemiology) [49], attrition in cohort studies of older people may
not be an inevitable indicator of selectivity and bias and a flawed
result.
Supporting Information
Appendix S1 Read codes and terms used for morbidi-
ties. Read codes and terms for the nine specific morbidities
included in the study. Read codes are a system of morbidity
recording commonly used in UK primary care [34].
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